Inventor · disambiguated record
Oleg Vechorkin
Also filed as: VECHORKIN OLEG
38 granted patents·12 pending applications·351 citations·filing 2014–2025
98Inventor score
Files withINCYTE CORP50
Top patents by PatentIndex Score
50 records- 0197US11542265B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Jan 3, 2023·8 cites·43 claims
- 0297US11492354B2Indazole compounds and uses thereofINCYTE CORP·Filed 2020·Granted Nov 8, 2022·8 cites·71 claims
- 0397US11242343B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2020·Granted Feb 8, 2022·12 cites·27 claims
- 0497US10934288B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Mar 2, 2021·13 cites·8 claims
- 0597US10745388B2Indazole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Aug 18, 2020·24 cites·22 claims
- 0697US10435405B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2018·Granted Oct 8, 2019·23 cites·16 claims
- 0797US9540347B2Pyridineamine compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jan 10, 2017·19 cites·70 claims
- 0896US11607416B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2020·Granted Mar 21, 2023·7 cites·52 claims
- 0996US10752635B2Indazole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Aug 25, 2020·16 cites·67 claims
- 1096US10722495B2Cyanoindazole compounds and uses thereofINCYTE CORP·Filed 2018·Granted Jul 28, 2020·24 cites·21 claims
- 1196US10266530B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2017·Granted Apr 23, 2019·24 cites·42 claims
- 1296US9802918B2Pyridineamine compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Oct 31, 2017·13 cites·16 claims
- 1395US11891388B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Feb 6, 2024·3 cites·30 claims
- 1495US11731958B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2020·Granted Aug 22, 2023·4 cites·25 claims
- 1595US11406624B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Aug 9, 2022·9 cites·16 claims
- 1695US10899755B2Benzothiazole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Jan 26, 2021·15 cites·39 claims
- 1795US10800761B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2019·Granted Oct 13, 2020·15 cites·12 claims
- 1894US11866426B2Benzothiazole compounds and uses thereofINCYTE CORP·Filed 2020·Granted Jan 9, 2024·3 cites·41 claims
- 1994US10280164B2Pyrazolopyridone compounds and uses thereofINCYTE CORP·Filed 2017·Granted May 7, 2019·24 cites·38 claims
- 2094US9822124B2Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2015·Granted Nov 21, 2017·13 cites·43 claims
- 2193US12384778B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2023·Granted Aug 12, 2025·1 cites·49 claims
- 2293US11795166B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Oct 24, 2023·2 cites·26 claims
- 2393US9920032B2Heterocyclic compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Mar 20, 2018·12 cites·31 claims
- 2492US11939331B2Tricyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2022·Granted Mar 26, 2024·4 cites·37 claims
- 2592US11299473B2Benzimidazole and indole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Apr 12, 2022·10 cites·56 claims
- 2692US11014929B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2019·Granted May 25, 2021·12 cites·54 claims
- 2791US12083124B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2023·Granted Sep 10, 2024·1 cites·30 claims
- 2891US11897891B2Tricyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2020·Granted Feb 13, 2024·5 cites·41 claims
- 2991US9556197B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jan 31, 2017·19 cites·48 claims
- 3088US10450296B2Heterocyclic compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2018·Granted Oct 22, 2019·6 cites·25 claims
- 3182US11111247B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Sep 7, 2021·1 cites·48 claims
- 3280US11053215B2Heterocyclic compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2019·Granted Jul 6, 2021·1 cites·12 claims
- 3380US2025057852A1Bicyclic heterocycles as fgfr inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3477US12466815B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2023·Granted Nov 11, 2025·0 cites·66 claims
- 3567US2025084063A1Bicyclic heterocycles as mrgprx2 antagonistsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3666US2024317744A1Bicyclic Ureas As Kinase InhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3765US12441731B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Oct 14, 2025·0 cites·54 claims
- 3865US2019315743A1Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Application pending·0 cites
- 3963US2025084087A1Bicyclic heterocycles as mrgprx2 antagonistsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4061US2025353842A1Bicyclic amine cdk12 inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 4160US12084453B2Bicyclic amines as CDK12 inhibitorsINCYTE CORP·Filed 2022·Granted Sep 10, 2024·0 cites·59 claims
- 4260US2018072718A1Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2017·Application pending·0 cites
- 4358US2023203010A1Bicyclic amine cdk12 inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 4457US12428420B2Tricyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2022·Granted Sep 30, 2025·0 cites·2 claims
- 4553US12122767B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2020·Granted Oct 22, 2024·0 cites·26 claims
- 4653US2018072741A1Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2017·Application pending·0 cites
- 4751US11591329B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2020·Granted Feb 28, 2023·0 cites·58 claims
- 4849US2025304582A1Bicyclic Ureas As Kinase InhibitorsINCYTE CORP·Filed 2025·Application pending·0 cites
- 4949US2018228786A1Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2018·Application pending·0 cites
- 5039US2025243208A1Bicyclic heterocycles as mrgprx2 antagonistsINCYTE CORP·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Oleg Vechorkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →